로딩 중…
지수 로딩 중…
Sinsin Pharmaceutical Co., Ltd
002800· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,270+1.18%
2026-08-04
Financials
Valuation Metrics
Sinsin Pharmaceutical Co., Ltd's Market Cap is ₩648B. At end of 2025 it was ₩889B. Ranked #1557 of 2,436 in KR market (top 64%), #909 of 1,649 on KOSDAQ (top 55%), #174 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 74%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 64.78B KRW | KR#1,557/2,436 Sec#174/234 |
| Revenue | 118.65B KRW | KR#1,306/2,436 Sec#83/234 |
| Net Income | 11.15B KRW | KR#870/2,436 Sec#55/234 |
| Total Assets | 141.48B KRW | KR#1,509/2,436 Sec#122/234 |
| Net Assets | 76.90B KRW | KR#1,581/2,436 Sec#131/234 |
| Employees | 352 | KR#684/2,436 Sec#61/234 |
| Value | ||
| P/E | 5.81x | KR#362/2,436 Sec#14/234 |
| P/B | 0.84x | KR#1,336/2,436 Sec#82/234 |
| PEG | 0.03x | KR#192/2,436 Sec#10/234 |
| P/S | 0.55x | KR#1,003/2,436 Sec#45/234 |
| EV/EBITDA | 7.97x | KR#458/2,436 Sec#16/234 |
| FCF Yield | 10.76% | KR#593/2,436 Sec#22/234 |
| Profitability | ||
| ROE | 14.50% | KR#257/2,436 Sec#16/234 |
| ROA | 7.88% | KR#350/2,436 Sec#27/234 |
| Op. Margin | 10.70% | KR#451/2,436 Sec#42/234 |
| Revenue Growth | 19.24% | KR#656/2,436 Sec#63/234 |
| Earnings Growth | 187.68% | KR#259/2,436 Sec#18/234 |
| Financial Health | ||
| Debt Ratio | 183.98% | KR#1,573/2,436 Sec#179/234 |
| Total Debt | 40.72B KRW | KR#1,062/2,436 Sec#74/234 |
| FCF | 6.97B KRW | KR#814/2,436 Sec#51/234 |
| Cash | 4.37B KRW | KR#2,047/2,436 Sec#185/234 |
| Current Ratio | 1.01x | KR#1,801/2,436 Sec#179/234 |
| Net Debt/EBITDA | 2.86x | KR#949/2,436 Sec#70/234 |
| Dividend | ||
| Div. Yield | 1.87% | KR#916/2,436 Sec#47/234 |
| Div. Growth | 33.33% | KR#315/2,436 Sec#16/234 |
| Performance | ||
| 1Y Return | -23.06% | KR#1,362/2,436 Sec#114/234 |
| 1M Return | -2.40% | KR#1,154/2,436 Sec#111/234 |
| From 52W High | -38.91% | KR#709/2,436 Sec#50/234 |
| 1Y MDD | -39.44% | KR#504/2,436 Sec#40/234 |
| Trading | ||
| Volume | 28,447 shares | KR#1,677/2,436 Sec#165/234 |
| Trading Value | 122.4M KRW | KR#1,657/2,436 Sec#173/234 |
| Foreign Own. | 6.20% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 735 KRW | KR#753/2,436 Sec#54/234 |
| BPS | 5,090 KRW | KR#1,421/2,436 Sec#104/234 |
Company Info
동사는 1959년 설립되어 2017년 코스닥에 상장된 외용제 OTC의약품 제조·판매 기업임. 첩부제, 에어로솔제, 액제 등을 생산하고 있으며, 파스, 물파스, 에어파스, 해충기피제, 외용액제 등을 포함한 약 100여 종의 OTC 의약품 및 의약외품을 생산하고 있음. 전국 주요 도시에 영업지점을 운영하며 1만2천여 소매약국과 직거래하고, OTC 영업 전문 인력 양성 프로그램을 통해 약국 직접 영업을 강화하고 있음. 신신제약는 1959년에 설립되었으며 세종특별자치시 소정면에 본사를 두고 있습니다.